Microcaps, a pioneer in advanced microencapsulation technology, has successfully raised CHF 9.3 million in a Series A financing round. This capital infusion will enable the company to scale-up its production capacity, addressing the increasing market demand for its innovative ethanol-free fine fragrance Perfume Pearls.
Microcaps, a leading innovator in advanced microencapsulation technology, has completed its Series A financing round, raising CHF 9.3 million. This substantial capital boost represents a pivotal moment for the company as it seeks to meet the growing demand for its unique ethanol-free fine fragrance product, Perfume Pearls. The Series A round attracted new private investors, expanding the company’s support network, with contributions from existing shareholders such as Helvetica Capital, Zürcher Kantonalbank, and the ETH Foundation. This robust financial backing highlights the continued confidence in Microcaps' vision and strategic direction.
"The roadshow had an incredible impact on me as an evolving entrepreneur," commented Alessandro Ofner, Co-CEO and Co-Founder of Microcaps. "This program opened a new world of opportunities and leapt forward for my entrepreneurship mind and our company."
Microcaps AG: Microencapsulation with Swiss precision
Microcapsules and microparticles are widely used to carry, deliver and protect pharmaceutical agents in drugs, fragrances in cosmetic products, and aromas or probiotics in food. However, todays ind... Read more